Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma

eLife

Volumn 6, Issue , 2017, Pages

  Fianco, Giulia ^a,b   Mongiardi, Maria Patrizia ^c   Levi, Andrea ^c   Luca, Teresa De ^d   Desideri, Marianna ^d   Trisciuoglio, Daniela ^d   Bufalo, Donatella Del ^d   Cinà, Irene ^b   Benedetto, Anna Di ^d   Mottolese, Marcella ^d   Gentile, Antonietta ^a,e   Centonze, Diego ^a,e   Ferrè, Fabrizio ^f   Barilà, Daniela ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c CNR   (Italy)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^e IRCCS NEUROMED   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TEMOZOLOMIDE; TUMOR NECROSIS FACTOR; VASCULOTROPIN; CASP8 PROTEIN, HUMAN; CYTOKINE; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; BIOINFORMATICS; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CANCER SURVIVAL; CELL PROLIFERATION ASSAY; CELL VIABILITY ASSAY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; DRUG RESISTANCE; GENE EXPRESSION PROFILING; METABOLISM; MICROARRAY ANALYSIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS;

CASPASE 8; CYTOKINES; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMANS; MICROARRAY ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 85023596687     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.22593     Document Type: Article

References (33)

1. Albulescu R, Codrici E, Popescu ID, Mihai S, Necula LG, Petrescu D, Teodoru M, Tanase CP. 2013. Cytokine patterns in brain tumour progression. Mediators of Inflammation 2013:979748. doi: 10.1155/2013/979748, PMID: 23864770
2. Ando M, Kawazu M, Ueno T, Fukumura K, Yamato A, Soda M, Yamashita Y, Choi YL, Yamasoba T, Mano H. 2013. Cancer-associated missense mutations of caspase-8 activate nuclear factor-kB signaling. Cancer Science 104:1002–1008. doi: 10.1111/cas.12191, PMID: 23659359
3. Bidère N, Snow AL, Sakai K, Zheng L, Lenardo MJ. 2006. Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-kappaB activation. Current Biology 16:1666–1671. doi: 10.1016/j.cub.2006.06. 062, PMID: 16920630
4. Bisio A, Zámborszky J, Zaccara S, Lion M, Tebaldi T, Sharma V, Raimondi I, Alessandrini F, Ciribilli Y, Inga A. 2014. Cooperative interactions between p53 and NFkB enhance cell plasticity. Oncotarget 5:12111–12125. doi: 10.18632/oncotarget.2545, PMID: 25401416
5. Bonavia R, Inda MM, Vandenberg S, Cheng SY, Nagane M, Hadwiger P, Tan P, Sah DW, Cavenee WK, Furnari FB. 2012. EGFRvIII promotes glioma angiogenesis and growth through the NF-kB, interleukin-8 pathway. Oncogene 31:4054–4066. doi: 10.1038/onc.2011.563, PMID: 22139077
6. Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, Ballard DW. 1995. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Molecular and Cellular Biology 15:2809–2818. doi: 10.1128/MCB.15.5.2809, PMID: 7739562
7. Cahill KE, Morshed RA, Yamini B. 2016. Nuclear factor-kB in glioblastoma: insights into regulators and targeted therapy. Neuro-Oncology 18:329–339. doi: 10.1093/neuonc/nov265, PMID: 26534766
8. Cursi S, Rufini A, Stagni V, Condò I, Matafora V, Bachi A, Bonifazi AP, Coppola L, Superti-Furga G, Testi R, Barilà D. 2006. Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression. The EMBO Journal 25:1895–1905. doi: 10.1038/sj.emboj.7601085, PMID: 16619028
9. Dunn GP, Rinne ML, Wykosky J, Genovese G, Quayle SN, Dunn IF, Agarwalla PK, Chheda MG, Campos B, Wang A, Brennan C, Ligon KL, Furnari F, Cavenee WK, Depinho RA, Chin L, Hahn WC. 2012. Emerging insights into the molecular and cellular basis of glioblastoma. Genes & Development 26:756–784. doi: 10.1101/gad.187922.112, PMID: 22508724
10. Fianco G, Cenci C, Barilà D. 2016. Caspase-8 expression and its Src-dependent phosphorylation on Tyr380 promote Cancer cell neoplastic transformation and resistance to anoikis. Experimental Cell Research 347:114– 122. doi: 10.1016/j.yexcr.2016.07.013, PMID: 27432652
11. Gabellini C, De Luca T, Trisciuoglio D, Desideri M, Di Martile M, Passeri D, Candiloro A, Biffoni M, Rizzo MG, Orlandi A, Del Bufalo D, Luca, DE, Martile, DI, Bufalo, D DEL. 2013. BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition. Carcinogenesis 34:2558–2567. doi: 10.1093/carcin/bgt242, PMID: 23836782
12. Graf RP, Keller N, Barbero S, Stupack D. 2014. Caspase-8 as a regulator of tumor cell motility. Current Molecular Medicine 14:246–254. doi: 10.2174/1566524014666140128111951, PMID: 24467204
13. Hanahan D, Weinberg RA. 2011. Hallmarks of Cancer: the next generation. Cell 144:646–674. doi: 10.1016/j.cell.2011.02.013, PMID: 21376230
14. Inda MM, Bonavia R, Mukasa A, Narita Y, Sah DW, Vandenberg S, Brennan C, Johns TG, Bachoo R, Hadwiger P, Tan P, Depinho RA, Cavenee W, Furnari F. 2010. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes & Development 24:1731–1745. doi: 10.1101/gad.1890510, PMID: 20713517
15. Juo P, Kuo CJ, Yuan J, Blenis J. 1998. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Current Biology 8:1001–1008. doi: 10.1016/S0960-9822(07)00420-4, PMID: 9740 801
16. Kargiotis O, Rao JS, Kyritsis AP. 2006. Mechanisms of angiogenesis in gliomas. Journal of Neuro-Oncology 78: 281–293. doi: 10.1007/s11060-005-9097-6, PMID: 16554966
17. Karin M, Cao Y, Greten FR, Li ZW. 2002. NF-kappaB in Cancer: from innocent bystander to Major culprit. Nature Reviews Cancer 2:301–310. doi: 10.1038/nrc780, PMID: 12001991
18. Khalifian S, Raimondi G, Brandacher G. 2015. The use of luminex assays to measure cytokines. Journal of Investigative Dermatology 135:1–5. doi: 10.1038/jid.2015.36, PMID: 25785953
19. Lemmers B, Salmena L, Bidère N, Su H, Matysiak-Zablocki E, Murakami K, Ohashi PS, Jurisicova A, Lenardo M, Hakem R, Hakem A. 2007. Essential role for caspase-8 in Toll-like receptors and NFkappaB signaling. Journal of Biological Chemistry 282:7416–7423. doi: 10.1074/jbc.M606721200, PMID: 17213198
20. Li B, Dewey CN. 2011. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12:323. doi: 10.1186/1471-2105-12-323, PMID: 21816040
21. Mantovani A, Allavena P, Sica A, Balkwill F. 2008. Cancer-related inflammation. Nature 454:436–444. doi: 10. 1038/nature07205, PMID: 18650914
22. Nogueira L, Ruiz-Ontañon P, Vazquez-Barquero A, Moris F, Fernandez-Luna JL. 2011. The nfkb pathway: a therapeutic target in glioblastoma. Oncotarget 2:646–653. doi: 10.18632/oncotarget.322, PMID: 21896960
23. O’Connor BD, Merriman B, Nelson SF. 2010. SeqWare Query Engine: storing and searching sequence data in the cloud. BMC Bioinformatics 11 Suppl 12:S2. doi: 10.1186/1471-2105-11-S12-S2, PMID: 21210981
24. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K. 2006. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157–173. doi: 10.1016/j.ccr.2006.02.019, PMID: 16530701
25. Pingoud-Meier C, Lang D, Janss AJ, Rorke LB, Phillips PC, Shalaby T, Grotzer MA. 2003. Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9:6401–6409. PMID: 14695141
26. Safa AR, Day TW, Wu CH. 2008. Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for Cancer therapy. Current Cancer Drug Targets 8:37–46. doi: 10.2174/156800908783497087, PMID: 18288942
27. Scharner D, Rössig L, Carmona G, Chavakis E, Urbich C, Fischer A, Kang TB, Wallach D, Chiang YJ, Deribe YL, Dikic I, Zeiher AM, Dimmeler S. 2009. Caspase-8 is involved in neovascularization-promoting progenitor cell functions. Arteriosclerosis, Thrombosis, and Vascular Biology 29:571–578. doi: 10.1161/ATVBAHA.108.182006, PMID: 19122169
28. Stagni V, Manni I, Oropallo V, Mottolese M, Di Benedetto A, Piaggio G, Falcioni R, Giaccari D, Di Carlo S, Sperati F, Cencioni MT, Barilà D. 2015. ATM kinase sustains HER2 tumorigenicity in breast cancer. Nature Communications 6:6886. doi: 10.1038/ncomms7886, PMID: 25881002
29. Stupack DG. 2013. Caspase-8 as a therapeutic target in Cancer. Cancer Letters 332:133–140. doi: 10.1016/j. canlet.2010.07.022, PMID: 20817393
30. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine 352:987–996. doi: 10.1056/NEJMoa043330, PMID: 15758009
31. Su H, Bidère N, Zheng L, Cubre A, Sakai K, Dale J, Salmena L, Hakem R, Straus S, Lenardo M. 2005. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 307:1465–1468. doi: 10.1126/science.1104765, PMID: 15746428
32. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O’Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, et al. 2010. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98–110. doi: 10.1016/j.ccr.2009.12.020, PMID: 20129251
33. Yeung YT, McDonald KL, Grewal T, Munoz L. 2013. Interleukins in glioblastoma pathophysiology: implications for therapy. British Journal of Pharmacology 168:591–606. doi: 10.1111/bph.12008, PMID: 23062197